Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

A 10-month-old boy with a rare combination of genetic conditions has severe immune deficiency and treatment challenges.

Taurine is important for many body functions and its deficiency can cause health problems.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Testosterone's effects on COVID-19 are unclear and need more research.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

A woman was allergic to quinine in her anti-hair loss lotion.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Minoxidil effectively controls blood pressure in severe cases, but has serious side effects and causes hair growth in women.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

*Acorus calamus* has many medicinal benefits but needs more safety research.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.